GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Omkar Pharmachem Ltd
Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial result ....
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 06 Aug 2026, 05:35 PM IST  ·  BSE ID: 88042f73-fd06-46b0-a006-000815f92018
View Original BSE Filing (PDF)
💡
In Simple Terms
Omkar Pharmachem's board will meet on August 13, 2026, to review and approve the company's financial results.
🤖 AI Summary
  • Omkar Pharmachem Ltd. board meeting scheduled for Thursday, August 13, 2026.
  • Board to consider and approve unaudited financial results for the quarter ended June 30, 2026.
  • Limited Review Report for the quarter ended June 30, 2026, will also be considered.
  • Trading window for designated persons remains closed until August 15, 2026, inclusive.
👥 What This Means For Shareholders
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
Shareholders will be affected once the financial results are published, as they will then have updated information on the company's performance for the quarter ended June 30, 2026.
🔍
Management Signal
The scheduled board meeting indicates management is adhering to regulatory timelines for financial reporting and transparency by preparing to release quarterly results.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome — check for approval of Q1 FY27 unaudited financial results.
Unaudited Financial Results for Q1 FY27 — analyze key performance metrics.
Limited Review Report for Q1 FY27 — assess auditor comments.
LOW RISK This filing is a routine intimation of a board meeting for financial results, carrying minimal inherent risk.
💡 Investor Takeaway
Omkar Pharmachem Ltd. board meeting scheduled for August 13, 2026, at 03:30 P.M. to consider and approve unaudited financial results for the quarter ended June 30, 2026, along with the Limited Review Report.
📅 Company Track Record
Omkar Pharmachem Ltd. was incorporated on October 25, 1995 (CIN: L93000GJ1995PLC025276). No previous financial results or material event filings were found for this company in recent context.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Omkar Pharmachem Ltd.'s next Board Meeting?
Omkar Pharmachem Ltd.'s Board of Directors meeting is scheduled for Thursday, August 13, 2026, at 03:30 P.M.
What is the purpose of Omkar Pharmachem Ltd.'s Board Meeting on August 13, 2026?
The purpose of the Board Meeting is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026, along with the Limited Review Report thereof.
When does the trading window for Omkar Pharmachem Ltd. close?
The trading window for dealing in shares of Omkar Pharmachem Ltd. remains closed until August 15, 2026, inclusive, for Designated Persons and their Immediate Relatives.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.